REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotop Pharmaceutical S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biotop Pharmaceutical S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biotop Pharmaceutical S.A. is a company based in Ecuador, with its head office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on August 27, 2012. The total number of employees is currently 6 (2023). In its most recent financial highlights, the company reported a net sales revenue increase of 141.45% in 2023. There was a total negative growth of 11.11% in Biotop Pharmaceutical S.A.’s total assets over the same period. The enterprise’s net profit margin increased by 13.4% in 2023.

Headquarters
Av. 6 de Diciembre N37-185, Mena Salazar Of.8a Bldg. , Floor 8
Quito; Pichincha;

Contact Details: Purchase the Biotop Pharmaceutical S.A. report to view the information.

Website: https://biotop-ecuador.com/

Basic Information
Total Employees:
Purchase the Biotop Pharmaceutical S.A. report to view the information.
Outstanding Shares:
Purchase the Biotop Pharmaceutical S.A. report to view the information.
Registered Capital:
Purchase the Biotop Pharmaceutical S.A. report to view the information.
Incorporation Date:
August 27, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Biotop Pharmaceutical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
141.45%
Total operating revenue
103.13%
Operating profit (EBIT)
87.64%
Net Profit (Loss) for the Period
60.76%
Total assets
-11.11%
Total equity
15.8%
Operating Profit Margin (ROS)
37.25%
Net Profit Margin
13.4%
Return on Equity (ROE)
14.1%
Quick Ratio
-0.05%
Cash Ratio
-0.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?